Global Anthelmintic Drugs Market Report By Type (Oral Drugs, Injectables), By Application (For Human, For Animal) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2023-2032

The global demand for Anthelmintic Drugs Market is presumed to reach the market size of nearly USD 4.69 BN by 2032 from USD 2.8 BN in 2023 with a CAGR of 5.27% under the study period 2024 - 2032.

Anthelmintic drugs are medications specifically designed to treat and eradicate parasitic worms, known as helminths, that infest the gastrointestinal tract and other tissues of humans and animals. These worms include various types, such as roundworms (nematodes), flatworms (trematodes and cestodes), and hookworms. Anthelmintics are essential for controlling and preventing parasitic infections in both humans and animals.

Market Dynamics

The Anthelmintic drugs market is driven by the global burden of parasitic infections, with a focus on neglected tropical diseases and zoonotic transmissions. High incidences of these infections, especially in regions with poor sanitation, propel the demand for effective anthelmintic treatments. Government initiatives, healthcare programs, and public health interventions contribute to accessibility, emphasizing the importance of these drugs in addressing global health challenges. In veterinary medicine, the growth of livestock farming and the economic impact of parasitic infections drive the demand for anthelmintics. Ongoing research and development efforts focus on drug innovation to combat emerging drug resistance and improve treatment efficacy. Increasing awareness, education, and globalization further contribute to the market's growth, reflecting the crucial role of anthelmintic drugs in both human and animal health. Collaborations within the pharmaceutical industry and a focus on research underscore the industry's commitment to providing effective solutions for parasitic infections and improving overall health outcomes.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of anthelmintic drugs. The growth and trends of anthelmintic drugs industry provide a holistic approach to this study. 

Market Segmentation

This section of the anthelmintic drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Type

• Oral Drugs
• Injectables

By Application

• For Human
• For Animal

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Anthelmintic Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Anthelmintic Drugs Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Anthelmintic Drugs market include Pfizer Inc., Merck & Co., Inc., Zoetis Inc., Bayer AG, Boehringer Ingelheim International GmbH, Novartis International AG, Elanco Animal Health, Virbac, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Norbrook Laboratories Limited, Agrimin Limited, Merial Animal Health Limited, Jurox Pty Limited among others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.